Aperio Technologies Hires Finance Executive
Digital Pathology Leader Continues to Scale Operations

(Back to Press Releases Page)

VISTA, CA – May 2, 2006 –Aperio Technologies, Inc., the leading provider of digital pathology systems to the Healthcare IT industry, announces that Richard Middelberg has joined the Company as vice president of finance and administration, reporting to Dirk Soenksen, CEO of Aperio. Richard will be responsible for leading the Company’s finance and administration departments and for building a scalable financial infrastructure to support the growing worldwide demand for the Company’s products.

"We are pleased to have a financial executive with Richard’s experience and skills joining the senior team,” said Soenksen. “Richard joins us at a time when we are focused on implementing scalable processes throughout the organization. His experience is ideally suited for assembling and managing the resources required for deploying sophisticated and scalable finance and accounting systems, including inventory management, which will integrate all elements of our order fulfillment process.”

Richard joins Aperio from dj Orthopedics, Inc., Vista, California, a leading supplier of rehabilitation and regeneration products for the nonoperative orthopedic and spine markets. At dj Orthopedics, Richard was vice president and general manager of the consignment inventory and insurance billing division. Previously he was chief financial officer of Global Digital Commerce.com, a start-up software company focused on e-commerce implementation, and prior to that he co-founded Medical Center Management, Inc., a multi-site management and investment company for radiology centers. Richard’s experience also includes management consulting at Bain & Company, and public accounting at Groupe Constantin.

Richard received an undergraduate degree from Dartmouth College, Hanover, New Hampshire and an MBA from the Wharton School at the University of Pennsylvania. He is also a CPA.

“I am excited to be joining Aperio at a time of rapid growth,” said Middelberg. “I look forward to working closely with the rest of the senior team to implement financial controls and processes that will allow Aperio to leverage its current leadership position in digital pathology and become a large and valuable company.”

About Digital Pathology and Virtual Microscopy

Virtual microscopy—the practice of converting entire glass microscope slides to high resolution digital slides that can be viewed, managed and analyzed—is the key technology that enables digital pathology. Digital pathology is a digital image-based environment for digital slide viewing and analysis that delivers consistent and accurate results, faster than traditional methods. It facilitates immediate access from anywhere to information obtained from glass microscope slides, and provides powerful tools for the instant archival and intelligent retrieval of histo-pathological data. Digital pathology is compatible with PACS (picture archiving and communication systems) and supports the vision of an enterprise-wide healthcare IT solution aimed at the electronic medical record (EMR).


About Aperio Technologies, Inc.

With the largest installed base of virtual microscopy systems, Aperio Technologies is a worldwide leader in virtual microscopy and digital pathology. Aperio’s ScanScope® scanners and software systems deliver integrated digital slide creation, viewing, management, and analysis capabilities to pathologists, and set the standard in digital pathology. Applications include tissue microarrays, toxicologic pathology, image analysis, workflow systems (PACS), telepathology, frozen sections, hematopathology, and cytopathology. Aperio’s web-based Spectrum™ digital pathology information management software delivers decision support information in context, with gross (macro) images, micro digital slide images, reports, case histories, and other associated documents and images cross-linked and concurrently viewable, anywhere, anytime. With headquarters in Vista, California, Aperio serves a global pathology market in research and education and is pursuing regulatory clearance to address digital slide-based diagnoses in the clinical market. For more information and to view a gallery of digital slides created by ScanScope Systems, please visit www.aperio.com.

 
* Aperio products are FDA cleared for specific clinical applications, and are intended for research use for other applications.